Prekovic S, Chalkiadakis T, Roest M, Roden D, Lutz C, Schuurman K, Opdam M, Hoekman L, Abbott N, Tesselaar T, Wajahat M, Dwyer AR, Mayayo-Peralta I, Gomez G, Altelaar M, Beijersbergen R, Győrffy B, Young L, Linn S, Jonkers J, Tilley W, Hickey T, Vareslija D, Swarbrick A, Zwart W. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. EMBO Mol Med. 2023. https://doi.org/10.15252/emmm.202317737.

Article  PubMed  Google Scholar 

He J, Wu M, Xiong L, Gong Y, Yu R, Peng W, Li L, Li L, Tian S, Wang Y. BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27. Clin Epigenetics. 2020;12:1–15.

Article  Google Scholar 

Tonsing-Carter E, Hernandez KM, Kim CR, Harkless RV, Oh A, Bowie KR, West-Szymanski DC, Betancourt-Ponce MA, Green BD, Lastra RR. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. Breast Cancer Res. 2019;21:1–15.

Article  Google Scholar 

Yang F, Ma Q, Liu Z, Li W, Tan Y, Jin C, Ma W, Hu Y, Shen J, Ohgi KA. Glucocorticoid receptor: MegaTrans switching mediates the repression of an ERα-regulated transcriptional program. Mol Cell. 2017;66: e326.

Article  Google Scholar 

Pan D, Kocherginsky M, Conzen S. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011;71:6360–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

West D, Kocherginsky M, Tonsing-Carter E, Dolcen D, Hosfield D, Lastra R, Sinnwell J, Thompson K, Bowie K, Harkless R. Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer. Clin Cancer Res. 2018;24:3433–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obradović MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux M-M, Münst S, Okamoto R, Kohler H, Schmidt A. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540–4.

Article  PubMed  Google Scholar 

Fallahpour S, Navaneelan T, De P, Borgo A. Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open. 2017;5(3):E734–9. https://doi.org/10.9778/cmajo.20170030.

Article  PubMed  PubMed Central  Google Scholar 

Rahman M, Jackson LK, Johnson WE, Li DY, Bild AH, et al. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics. 2015;31(22):3666–72. https://doi.org/10.1093/bioinformatics/btv377.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berkel C, Cacan E. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer. Hum Cell. 2021;34(3):862–77. https://doi.org/10.1007/s13577-021-00486-3.

Article  CAS  PubMed  Google Scholar 

Berkel C, Cacan E. Copy number and expression of CEP89, a protein required for ciliogenesis, are increased and predict poor prognosis in patients with ovarian cancer. Cell Biochem Funct. 2022;40(3):298–309. https://doi.org/10.1002/cbf.3694.

Article  CAS  PubMed  Google Scholar 

Morgan M, Shepherd L. ExperimentHub: Client to access ExperimentHub resources. R package version 2.4.0; 2022.